The human brain appears to rewire how its genome is regulated starting in midlife, according to a study published in Science that mapped gene regulation and three-dimensional genome organization in individual cells taken from the human hippocampus, the region central to learning and memory. By sampling adults across a wide age range, the researchers assembled one of the most detailed accounts to date of what happens to genome regulation as the brain ages.
The sharpest signal came from microglia, the immune cells that patrol and maintain brain tissue. Between roughly ages 50 and 75, the population of microglia that originate during embryonic development dropped steeply. In their place, the team found cells whose molecular profiles looked more like immune cells circulating in the blood.
That runs against a long-held assumption in neuroscience: that the microglia laid down early in development stick around for life. The replacement cells also carried stronger inflammatory signatures, which raises the prospect that this turnover feeds the chronic, low-grade inflammation seen in older brains. Since age is by far the strongest risk factor for Alzheimer's and other neurodegenerative conditions, a midlife shift in the brain's immune cell population is a plausible piece of that puzzle.
What the study establishes is a pattern, not a cause. It describes when and how these cells change in donated human tissue; it does not show that the swap triggers disease, and it will take further work to determine whether the newer, more inflammatory cells help drive neurodegeneration or simply accompany it.